How an Unproven Alzheimer’s Drug Bought Authorised
Although a few of its personal senior officers mentioned there was little proof of profit for sufferers, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.
Source link
Although a few of its personal senior officers mentioned there was little proof of profit for sufferers, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.
Source link